Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$347.95M
Close$
$-26.42
332.1% downside
Current Fair Value
332.1% downsideOvervalued by 332.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $347.95 Million |
|---|---|
| Enterprise Value | $161.40 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3 |
| Beta | 3.41 |
| Outstanding Shares | 27,000,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.28 |
|---|---|
| PEG | 3.46 |
| Price to Sales | 2.28 |
| Price to Book Ratio | 1.42 |
| Enterprise Value to Revenue | 1.09 |
| Enterprise Value to EBIT | -3.17 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
ESG Score
No data